Directory

>

Kenneth Brouwer Drph

avatar

Kenneth Brouwer Drph

Vice President - Technology ADME-TOX | BioIVT

Durham, North Carolina, United States

View contact details (it's free)

Kenneth Brouwer Drph

Summary

Dr. Kenneth Brouwer is an accomplished leader in the pharmaceutical industry, currently serving as Vice President of Technology, ADME-TOX at BioIVT. With a robust background in pharmacokinetics and drug metabolism, he has held pivotal roles in various organizations, including Chief Scientific Officer at Qualyst Transporter Solutions and Executive Director at PPD Discovery. Dr. Brouwer has over 18 years of experience at GlaxoSmithKline, where he directed large international project teams and contributed to regulatory submissions. He holds a Ph.D. in Pharmacokinetics/Drug Metabolism and has specialized in hepatic transport and drug interactions. His expertise extends to clinical development and toxicology, making him a sought-after expert in his field. Dr. Brouwer's passion for innovation is evident in his work on pioneering drug screening technologies. He is also an advocate for the integration of natural products in drug development, focusing on safety frameworks for drug interactions.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Kenneth Brouwer Drph

Work Experience

company logo

Vice President - Technology ADME-TOX at

BioIVT

January 2018 - Present

company logo

Chief Scientific Officer at

Qualyst Transporter Solutions, LLC

April 2012 - January 2018

company logo

Chief Scientific Officer at

Qualyst Transporter Solutions, LLC

January 2003 - May 2012

company logo

Executive Director, PreClinical Sciences at

PPD

January 2002 - January 2003

company logo

Director, PreClinical Development at

GSK

January 1996 - January 2002

company logo

Senior Scientist - Drug Metabolism at

Glaxo

January 1986 - January 1996

Logos provided by Logo.dev

Kenneth Brouwer Drph

Education

American University

January 1999 - January 2000

University of Kentucky, Ph.D.

January 1982 - January 1986

Ferris State University, B.S., Rph.

January 1979 - January 1982

Aquinas College - Grand Rapids

January 1977 - January 1978

Hope College, B.A.

January 1972 - January 1976

Frequently Asked Questions about Kenneth Brouwer Drph

What is Kenneth Brouwer Drph email address?

Kenneth Brouwer Drph's primary email address is ********@bioivt.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Kenneth Brouwer Drph work for?

Kenneth Brouwer Drph is a Vice President - Technology ADME-TOX at BioIVT, a company specializing in Commercial physical research.

Where Kenneth Brouwer Drph graduated from?

Kenneth Brouwer Drph holds a degree in Organizational Change Leadership from American University.

How can I directly contact Kenneth Brouwer Drph?

To contact Kenneth Brouwer Drph directly, you can use the email address ********@bioivt.com. Complete contact information is available upon registration with Muraena.

Who is Kenneth Brouwer Drph?

Dr. Kenneth Brouwer is an accomplished leader in the pharmaceutical industry, currently serving as Vice President of Technology, ADME-TOX at BioIVT. With a robust background in pharmacokinetics and drug metabolism, he has held pivotal roles in various organizations, including Chief Scientific Officer at Qualyst Transporter Solutions and Executive Director at PPD Discovery. Dr. Brouwer has over 18 years of experience at GlaxoSmithKline, where he directed large international project teams and contributed to regulatory submissions. He holds a Ph.D. in Pharmacokinetics/Drug Metabolism and has specialized in hepatic transport and drug interactions. His expertise extends to clinical development and toxicology, making him a sought-after expert in his field. Dr. Brouwer's passion for innovation is evident in his work on pioneering drug screening technologies. He is also an advocate for the integration of natural products in drug development, focusing on safety frameworks for drug interactions.

Kenneth`s contact details

mail

********@bioivt.com

**************@qualyst.com

***********@mindspring.com

****@att.net

*******@ppdi.com

Colleagues

avatar
Parijat Jain

Vice President and General Manager, Cell & Gene Therapy Business

avatar
Richard Haigh

Chief Executive Officer

avatar
Shannon Richey

Vice President & General Manager, Asterand Bioscience Detroit Operations

avatar
Clifford Raynor

Senior Vice President, Quality And Regulatory

avatar
Courtney Noah

VP, Scientific Affairs

avatar
Ehab Alramahy

Senior Vice President/GM | Disease State & CGT Business

avatar
Christopher Black

Senior Vice President, ADME-Tox Division

avatar
Brian Ogilvie

Vice President of Scientific Consulting

Chad Pallett

Acting CISO

avatar
Charlie Chungu

Vice President of Marketing

View Contact details (it's free)
Request Profile Removal